Showing results (161-170 of 11,666) with videos related to
Sort By:
Pageof 1,167
Clinical Nuclear Medicine|May 11, 2023
Safety and Efficacy of 177 Lu-DOTATATE in Neuroendocrine Tumor Patients With Extensive Bone DiseaseShahad Alsadik, Gopinath Gnanasegaran, Luohai Chen, et al.Clinical Nuclear Medicine|May 11, 2023
Impact of CXCR4-Directed PET/CT on Staging and Proposed Oncologic Management in Patients With Digestive System TumorsAlexander Weich, Sebastian E Serfling, Wiebke Schlötelburg, et al.Clinical Nuclear Medicine|May 23, 2023
Cerebellar Hypermetabolism in a Hodgkin Lymphoma Leads to Diagnosis of Paucisymptomatic Cryptococcus neoformans MeningitisEef Vanerwegen, Niloefar Ahmadi Bidakhvidi, Vibeke K J Vergote, et al.Clinical Nuclear Medicine|May 23, 2023
FAPI-Negative FDG-Avid Metastatic Relapse of Breast Cancer on PET/CTCaner Civan, Duygu Has Simsek, Emine Goknur Isik, et al.Clinical Nuclear Medicine|July 13, 2015
Umbilical Plugoma Mimics Melanoma Metastasis on FDG PET/CTYazan Z Alabed, Christopher SakellisClinical Nuclear Medicine|July 13, 2015
Metastatic Midgut Carcinoid in the MyocardiumJakub Bukowczan, Konstantinos B Lois, Jane Skinner, et al.Clinical Nuclear Medicine|July 13, 2015
Preablative Stimulated Thyroglobulin Levels Can Predict Malignant Potential and Therapeutic Responsiveness of Subcentimeter-Sized, 18F-fluorodeoxyglucose-Avid Cervical Lymph Nodes in Patients With Papillary Thyroid CancerSeong Young Kwon, Jahae Kim, Se Hee Jung, et al.Clinical Nuclear Medicine|July 13, 2015
The Deauville 5-Point Scale Improves the Prognostic Value of Interim FDG PET/CT in Extranodal Natural Killer/T-Cell LymphomaChong Jiang, Minggang Su, Russell Oliver Kosik, et al.Clinical Nuclear Medicine|June 9, 2015
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node MappingMauro Signorelli, Cinzia Crivellaro, Alessandro Buda, et al.Pageof 1,167